Compound information
- Natural Products
- ZC2457261
- Molecular Formula
- C26H41N3O5
- Molecular Weight
- 475.304621412 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-[[(1S)-1-[[(1R)-1-formylpentyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C26H41N3O5/c1-6-7-13-21(16-30)27-24(31)22(14-18(2)3)28-25(32)23(15-19(4)5)29-26(33)34-17-20-11-9-8-10-12-20/h8-12,16,18-19,21-23H,6-7,13-15,17H2,1-5H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22+,23-/m1/s1
- InChI Key
- RNPDUXVFGTULLP-XPWALMASSA-N
- SMILES
- CCCC[C@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000044682040
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.6 Å2 | LogP | 4.657 |
LogS | -4.491 | LogD | 4.878 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.994 | Pgp substrate | 0.087 |
HIA | 0.96 | F20 % | 0.991 |
F30 % | 0.778 | Caco-2 | -4.765 |
MDCK | -5.05 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.777 | PPB | 71.742 |
VD | 0.485 | Fu | 1.423 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.625 |
CYP2A6 substrate | 0.266 | CYP2B6 substrate | 0.418 |
CYP2C19 inhibitor | 0.808 | CYP2C19 substrate | 0.841 |
CYP2C8 substrate | 0.695 | CYP2C9 inhibitor | 0.283 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.526 | CYP2E1 substrate | 0.295 |
CYP3A4 inhibitor | 0.952 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.829 | CL | 6.163 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.008 | Hepatotoxicity | 0.988 |
Mutagenicity | 0.066 | Rat Oral Acute Toxicity | 0.638 |
FDAMDD | 0.346 | Skin Sensitization | 0.894 |
Carcinogenicity | 0.024 | Eye Corrosion | 0.007 |
Eye Irritation | 0.016 | Respiratory Toxicity | 0.034 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.163 | IGC50 | 3.837 |
LC50FM | 4.301 | LC50DM | 5.133 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.192 | NR-AR-LBD | 0.372 |
NR-AhR | 0.006 | NR-Aromatase | 0.035 |
NR-ER | 0.386 | NR-ER-LBD | 0.348 |
NR-PPAR-gamma | 0.39 | SR-ARE | 0.635 |
SR-ATAD5 | 0.274 | SR-HSE | 0.079 |
SR-MMP | 0.137 | SR-p53 | 0.051 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.